These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1810066)

  • 1. [The use of pantothenic acid preparations in treating patients with viral hepatitis A].
    Komar VI
    Ter Arkh; 1991; 63(11):58-60. PubMed ID: 1810066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of water-soluble vitamins in viral hepatitis A].
    Komar VI; Vasil'ev VS
    Klin Med (Mosk); 1992 Jan; 70(1):73-5. PubMed ID: 1608218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Humoral and cellular indices of nonspecific resistance in viral hepatitis A and ascorbic acid].
    Vasil'ev VS; Komar VI; Kisel' NI
    Ter Arkh; 1989; 61(11):44-6. PubMed ID: 2633390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic efficacy of pantothenic acid preparations in ischemic heart disease patients].
    Borets VM; Lis MA; Pyrochkin VM; Kishkovich VP; Butkevich ND
    Vopr Pitan; 1987; (2):15-7. PubMed ID: 3590676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of amben on the immunological reactivity indices in viral hepatitis A].
    Litvinenko NG
    Vrach Delo; 1984 Oct; (10):113-6. PubMed ID: 6334935
    [No Abstract]   [Full Text] [Related]  

  • 6. [Leukergic reaction in viral hepatitis to antibacterial preparations].
    Andreĭchin MA; Donich NS; Vasil'eva NA
    Antibiotiki; 1982 Oct; 27(10):784-7. PubMed ID: 7149687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium pantothenate in arthritic conditions. A report from the General Practitioner Research Group.
    Practitioner; 1980 Feb; 224(1340):208-11. PubMed ID: 6988826
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary excretion of microbiologically detectable forms of pantothenic acid in viral hepatitis].
    Moĭseenok AG; Komar VI; Denisova NK; Khil'manovich AP
    Vopr Pitan; 1981; (4):18-22. PubMed ID: 7293099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pantothenic acid in maintaining thiol and immune homeostasis.
    Moiseenok AG; Komar VI; Khomich TI; Kanunnikova NP; Slyshenkov VS
    Biofactors; 2000; 11(1-2):53-5. PubMed ID: 10705960
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of the ecologically adverse factors of a Donets Basin industrial region on the clinico-immunological indices of patients with viral hepatitis A and B].
    Petrunia AM; Frolov VM; Peresadin NA; Dekaliuk IV
    Lik Sprava; 1994; (5-6):99-103. PubMed ID: 7831925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The rehabilitation of patients with a history of viral hepatitis using UHF therapy (460 MHz)].
    Filimonov RM; Spakhov KV; Ruzova TK
    Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (6):26-8. PubMed ID: 9484027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinico-immunological evaluation of the ribomunyl treatment of chronic bronchitis patients].
    Borisova AM; Khoroshilova NV; Pinegin BV; Eremina OF; Simonova AV; Kulakov AV; Golubeva NM; Dykhanov II
    Ter Arkh; 1994; 66(3):46-50. PubMed ID: 8202852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of trental in combined treatment of viral hepatitis].
    Vasil'ev VS; Pron'ko NV
    Klin Med (Mosk); 1990 Mar; 68(3):68-70. PubMed ID: 2370759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indices of immunity and allergy in patients with viral hepatitis treated with prodigiozan].
    Rudchik AS; Andreĭchin MA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):45-9. PubMed ID: 3364072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current approaches to using beta-carotenoids in chronic hepatitis in flight personnel].
    Preobrazhenskiĭ VN; Vasilenko VV
    Aviakosm Ekolog Med; 1996; 30(3):45-6. PubMed ID: 8963295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of prodigiozan and zymosan in treating children with viral hepatitis A].
    Lebenzon SS; Maianskiĭ DN; Gavrilova NI; Kutina SN
    Pediatriia; 1988; (6):27-30. PubMed ID: 3186403
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The cyclophosphamide treatment of glomerulonephritis patients].
    Dorets'kyĭ VV
    Vrach Delo; 1991 Feb; (2):51-3. PubMed ID: 2058123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative characteristics of immunologic indices in patients with lung abscesses and viral hepatitis].
    Sokhin AA; Monogarova NE; Kurilova VG; Sliusar' LI; Sokhina GT
    Vrach Delo; 1989 Aug; (8):116-9. PubMed ID: 2588507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antioxidant correction of cytogenetic disorders in viral hepatitis].
    Peresadin NA; Frolov VM; Pinskiĭ LL
    Lik Sprava; 1995; (1-2):76-9. PubMed ID: 7483554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.